Big Pharma Front Groups Muddle Debate Over Drug Prices, Patient Advocates Say
Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.
Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.
The U.S. "has always accepted that we are the country that overpays relative to the rest of the world," said one health policy expert.
"As Congress works toward finalizing an end-of-year budget package, we urge the chambers to include bipartisan legislation to address abuse of the Food and Drug Administration's citizen petition process in…
"We must put an end to drug corporations' unfettered ability to dictate prices at the expense of patients."